✦ LIBER ✦

Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy

✍ Scribed by Kazuhiko Yoshimatsu; Hiroyuki Kato; Keiichiro Ishibashi; Masahiko Hashimoto; Arihiro Umehara; Hajime Yokomizo; Kiyohito Yoshida; Takashi Fujimoto; Kiyo Iwasaki; Kenji Ogawa

Book ID: 105991852
Publisher: Springer
Year: 2003
Tongue: English
Weight: 181 KB
Volume: 52
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-003-0686-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1866 THE EFFICIENCY OF SECOND-LINE CHEMO

1866 THE EFFICIENCY OF SECOND-LINE CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL FOR ADVANCED UROTHELIAL CARCINOMA RESISTANT TO CISPLATIN-BASED CHEMOTHERAPY

✍ Nishihara, Chikako; Kuratsukuri, Katsuyuki; Iguchi, Taro; Tamada, Satoshi; Tanak 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 130 KB

736 - Consistent safety and efficacy res

736 - Consistent safety and efficacy results in 2 study populations treated with irinotecan (CPT-11) for metastatic colorectal cancer (MCRC) resistant to 5-FU

✍ R. Guimbaud; R. Bugat; E. Van Cutsem; D. Mignard; M. Mahjoubi; P. Canal; C. Blan 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Protracted continuous infusion of 5-fluo

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

✍ Alfredo Falcone; Giacomo Allegrini; Monica Lencioni; Elisabetta Pfanner; Isa Bru 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 72 KB

OP4. Cost-effectiveness of Irinotecan (C

OP4. Cost-effectiveness of Irinotecan (CPT-11) and best estimated chemotherapy regimen in patients with metastatic colorectal cancer after failure of 5fluorouracil (5FU) containing regimen: Results based on a phase III trial

✍ G Blijham; C Schmitt; P Aussage; B Henry-Launois; B Jolain; P Hérait 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB